healthcare

Image for WeightWatchers partners with Amazon for easy weight-loss drug deliveryFinance

WeightWatchers Partners With Amazon for Easy Weight-Loss Drug Delivery

Image for Novo, Lilly's shares drop as Trump vows weight-loss drug price cutsFinance

Novo, Lilly's Shares Drop as Trump Vows Weight-Loss Drug Price Cuts

Image for China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with RocheHeadlines

China's Hansoh Signs up to $1.45 Billion Deal for Colorectal Cancer Drug With Roche

Image for UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drugHeadlines

UK's Drug-Cost Watchdog Recommends Use of Gsk Unit's Hiv Prevention Drug

Image for Trump, Merck KGaA announce deal to cut some IVF drug prices

Trump, Merck KGaA Announce Deal to Cut Some Ivf Drug Prices

Date: October 16, 2025

By Patrick Wingrove (Reuters) -U.S. President Donald Trump and Germany's Merck KGaA on Thursday said they had struck a deal that would cut the cost of some drugs needed for in-vitro fertilization in...

Image for Trump says price of Ozempic will be lowered

Trump Says Price of Ozempic Will Be Lowered

Date: October 16, 2025

WASHINGTON (Reuters) -U.S. President Donald Trump said on Thursday that the price of Novo Nordisk's best-selling weight-loss drug would be lowered and that negotiations over price changes would be...

Image for Roche to sell flu pill for $50 to cash-paying US patients

Roche to Sell Flu Pill for $50 to Cash-Paying US Patients

Date: October 16, 2025

By Patrick Wingrove (Reuters) -Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price of $50, following similar moves by rivals as...

Image for Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares

Germany's Merck Eyes Life Science Deals, but Muted 2026 Outlook Knocks Shares

Date: October 16, 2025

By Marleen Kaesebier (Reuters) -German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on...

Image for Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

Novo Nordisk Signs up to $2.1 Billion Licensing Deal With Omeros in Rare Disease Push

Date: October 15, 2025

(Reuters) -Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and...

Image for India's Infosys wins $1.6 billion deal from UK's National Health Service

India's Infosys Wins $1.6 Billion Deal From UK's National Health Service

Date: October 14, 2025

BENGALURU (Reuters) -India's Infosys said on Tuesday it has won a 1.2 billion pound ($1.59 billion) deal from the UK's National Health Services Business Services Authority. The tenure of the deal will...